Rigel Pharmaceuticals Inc
RIGLNasdaqCIK 1034842HealthcareFiscal year ends Dec 31
Reports and events: 280 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001034842-26-000053 |
| 2026-08-0416:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001034842-26-000052 |
| 2026-07-0116:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001034842-26-000045 |
| 2026-06-1716:05 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0001034842-26-000043 |
| 2026-05-2016:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001034842-26-000041 |
| 2026-05-1217:24 ET | 8-K | 1.01 Entry into a material agreement | 0001034842-26-000038 |
| 2026-05-0516:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001034842-26-000033 |
| 2026-05-0516:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001034842-26-000032 |
| 2026-04-2116:18 ET | 8-K | 1.02 Termination of a material agreement | 0001034842-26-000027 |
| 2026-04-0316:01 ET | DEF 14A | Proxy statementPeriod 2026-05-14 | 0001034842-26-000023 |
| 2026-03-0316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001034842-26-000016 |
| 2026-03-0316:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001034842-26-000015 |
| 2026-02-0316:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001034842-26-000007 |
| 2026-01-1208:15 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001034842-26-000005 |
| 2025-12-1016:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-119976 |
| 2025-11-0416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-106282 |
| 2025-11-0416:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-106268 |
| 2025-08-0516:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010281 |
| 2025-08-0516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074163 |
| 2025-05-2316:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-25-052407 |
| 2025-05-0616:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045067 |
| 2025-05-0616:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006493 |
| 2025-04-1016:06 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001140361-25-013250 |
| 2025-03-2709:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-028564 |
| 2025-03-1017:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-022224 |
| 2025-03-0416:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-020313 |
| 2025-03-0416:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002169 |
| 2025-01-1308:15 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-002874 |
| 2024-12-0916:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-126758 |
| 2024-11-0716:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115334 |
| 2024-11-0716:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014862 |
| 2024-09-1916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-101327 |
| 2024-09-0308:30 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-24-096047 |
| 2024-08-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086271 |
| 2024-08-0616:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011079 |
| 2024-06-2716:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-075697 |
| 2024-06-2508:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-074574 |
| 2024-05-2916:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-24-066058 |
| 2024-05-0716:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058017 |
| 2024-05-0716:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007041 |
| 2024-04-1208:05 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-24-046527 |
| 2024-04-1016:49 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001140361-24-019133 |
| 2024-03-0516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-031010 |
| 2024-03-0516:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-002475 |
| 2024-02-2208:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition | 0001104659-24-026338 |
| 2024-01-0808:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-002085 |
| 2023-11-3006:04 ET | 8-K | 3.01 Delisting notice | 0001104659-23-122171 |
| 2023-11-0716:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115245 |
| 2023-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017987 |
| 2023-08-0116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-086368 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.